Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2014 2
2015 4
2016 6
2017 6
2018 2
2021 1
2022 6
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Continuing evidence that COVID-19 has influenced syphilis epidemiology in Rome.
Latini A, Magri F, Giuliani E, Giuliani M, Garelli V, Pontone M, Salvi M, Stingone C, Gianserra L, Pimpinelli F, Buonomini AR, Morrone A, Donà MG, Zaccarelli M. Latini A, et al. Among authors: gianserra l. Sex Transm Infect. 2022 Feb;98(1):72. doi: 10.1136/sextrans-2021-055250. Epub 2021 Sep 20. Sex Transm Infect. 2022. PMID: 34544886 No abstract available.
Is HCV elimination among persons living with HIV feasible? Data from the NoCo study in the setting of the ICONA cohort.
d'Arminio Monforte A, Tavelli A, Rossotti R, Gagliardini R, Saracino A, Lo Caputo S, Sala M, Quiros-Roldan E, Mussini C, Girardi E, Cozzi-Lepri A, Antinori A, Puoti M; NoCo Study of the Icona cohort. d'Arminio Monforte A, et al. Liver Int. 2023 Oct;43(10):2130-2141. doi: 10.1111/liv.15700. Epub 2023 Aug 31. Liver Int. 2023. PMID: 37649460 Free article.
False negative RPR test with prozone phenomenon in an HIV-negative man with secondary syphilis.
Sernicola A, Maddalena P, La Greca I, Donà MG, Salvi M, Garelli V, Stingone C, Gianserra L, Giuliani E, Pontone M, Pimpinelli F, Latini A. Sernicola A, et al. Among authors: gianserra l. J Eur Acad Dermatol Venereol. 2022 Aug;36(8):e628-e629. doi: 10.1111/jdv.18089. Epub 2022 Mar 28. J Eur Acad Dermatol Venereol. 2022. PMID: 35305047 No abstract available.
Long-term outcomes of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy and as switch strategy in virologically suppressed persons with HIV: data from the ICONA cohort.
d'Arminio Monforte A, Tavelli A, Di Biagio A, Sarmati L, Marchetti GC, Bai F, Cingolani A, Quiros Roldan E, Mussini C, Lichtner M, Vergori A, Piconi S, Orofino G, Fusco FM, Bandera A, Nozza S, Castagna A, Antinori A; ICONA Foundation Study Group. d'Arminio Monforte A, et al. J Antimicrob Chemother. 2024 Apr 6:dkae081. doi: 10.1093/jac/dkae081. Online ahead of print. J Antimicrob Chemother. 2024. PMID: 38581349
Determinants of worse liver-related outcome according to HDV infection among HBsAg positive persons living with HIV: Data from the ICONA cohort.
d'Arminio Monforte A, Tavelli A, Salpini R, Piermatteo L, D'Anna S, Carrara S, Malagnino V, Mazzotta V, Brancaccio G, Marchetti GC, Rosselli Del Turco E, Rossotti R, Mussini C, Antinori A, Lo Caputo S, Ceccherini Silberstein F, Gaeta GB, Svicher V, Puoti M; Icona Foundation Study Group. d'Arminio Monforte A, et al. Liver Int. 2024 Feb;44(2):603-613. doi: 10.1111/liv.15804. Epub 2023 Dec 15. Liver Int. 2024. PMID: 38100128 Free article.
Features of fragile people with SARS-CoV-2 infection in isolation in a COVID-19 hotel in Rome, Italy.
Stingone C, Latini A, Gianserra L, Salvi M, Donà MG, Giuliani E, Lesnoni La Parola I, Mussi A, Cameli N, Garelli V, Giuliani M, Buonomini AR, Vujovic B, Cerimele M, Morrone A. Stingone C, et al. Among authors: gianserra l. Eur Rev Med Pharmacol Sci. 2022 Apr;26(7):2631-2638. doi: 10.26355/eurrev_202204_28501. Eur Rev Med Pharmacol Sci. 2022. PMID: 35442479 Free article.
26 results